Associated Press Haemonetics Corp. in Braintree said Monday its profit grew 22 percent in the fiscal second quarter due to improved revenue from products used in collecting blood plasma. The blood collection and processing... [read full story]
|
RELATED
|
|
Haemonetics Corporation (NYSE: HAE - News) reported strong results for the second quarter of fiscal 2010. Earnings per share were 69 cents, beating the Zacks Consensus Estimate of 65 cents and the year-ago earnings of 58 cents....
BRAINTREE, Mass. - Haemonetics Corp. said Monday its profit grew 22 percent in the fiscal second quarter due to improved revenue from products used in collecting blood plasma. The blood collection and processing systems maker...
Haemonetics profit rises on improved plasma and platelet revenue, company backs forecasts BRAINTREE, Mass. (AP) -- Haemonetics Corp. said Monday its profit grew 22 percent in the fiscal second quarter due to improved revenue...
BRAINTREE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE - News) reported second quarter GAAP net revenues of $157 million, up 8%, net income of $18 million, up 22%, and earnings per share of $0.69,...
Company Affirms Full Year Revenue and EPS Guidance BRAINTREE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Adjusted year-to-date net income growth is 18% and earnings per share are up 18%.(1) Haemonetics ended the second quarter...
BRAINTREE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) reported second quarter GAAP net revenues of $157 million, up 8%, net income of $18 million, up 22%, and earnings per share of $0.69, up...
BRAINTREE, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Free cash flow $28,982 $15,799 ======= ======= Haemonetics Corporation Financial Summary Reconciliation of Non-GAAP Measures Haemonetics has presented supplemental non-GAAP...
Finance, Banking & Insurance, Investing & Markets, Financial Markets, Stock Markets, Haemonetics
